Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of $0.45, $0.21 better than the analyst estimate of $0.24. Revenue for the quarter came in at $48.5 million versus the consensus estimate of $57 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.